0001694665-23-000002.txt : 20230123
0001694665-23-000002.hdr.sgml : 20230123
20230123173506
ACCESSION NUMBER: 0001694665-23-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230119
FILED AS OF DATE: 20230123
DATE AS OF CHANGE: 20230123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARRIERE STEPHEN J
CENTRAL INDEX KEY: 0001239844
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38473
FILM NUMBER: 23545361
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evelo Biosciences, Inc.
CENTRAL INDEX KEY: 0001694665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465594527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 620 MEMORIAL DRIVE SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-577-0300
MAIL ADDRESS:
STREET 1: 620 MEMORIAL DRIVE SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_167451329279844.xml
FORM 4
X0306
4
2023-01-19
0
0001694665
Evelo Biosciences, Inc.
EVLO
0001239844
CARRIERE STEPHEN J
C/O EVELO BIOSCIENCES, INC.
620 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
0
1
0
0
Principal Accounting Officer
Common Stock
2023-01-19
4
M
0
354
A
354
D
Common Stock
2023-01-23
4
S
0
151
1.0604
D
203
D
Restricted Stock Units
0.0
2023-01-19
4
M
0
354
0
D
2032-01-19
Common Stock
354.0
1063
D
Settlement of shares of Common Stock acquired upon the vesting of Restricted Stock Units previously granted to the reporting person.
The price is N/A.
The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units previously granted to the reporting person. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.06 to $1.0712, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
The Restricted Stock Units vest in four substantially equal annual installments at the end of each annual anniversary of the date of grant, subject to continued employment on such dates.
/s/ Stephen J. Carriere
2023-01-23